3 天
Investor's Business Daily on MSNAlnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBioAlnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.
VPN usage in Turkey has spiked significantly following reports of social media restrictions and the arrest of President ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果